Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
The significance of this is that RVX must be getting data on ALP and eGFR for all patients in their Phase 3 trial. They can see if some are seeing improvements in ALP and eGFR. As a result, they must have an excellent idea of whether Phase 3 is going as expected.
My hunch is that they are seeing great results. Alongwith the 8 safety reviews, we most likely have a block buster drug on our hands.
